Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

RGNXRGNX
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in REGENXBIO INC

GOLDMAN SACHS GROUP INC holds 1.8M shares of RGNX (REGENXBIO INC), worth $15.4M as of 2026-Q1. The position was increased (+3.0% shares). RGNX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$15.4M

Current Shares

1.8M

Total Value Change

+$9.6M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.8M
+3.0%
$15.4M0.0%$8.69
29
2025-Q4
Decreased
1.8M
-3.6%
$25.7M0.0%$14.09
0
2025-Q3
Increased
1.9M
+3.8%
$17.9M0.0%$9.85
29
2025-Q2
Increased
1.8M
+137.1%
$14.7M0.0%$8.39
45
2025-Q1
Decreased
752,727
-0.5%
$5.4M0.0%$7.83
0
2024-Q4
New
756,238
-
$5.8M0.0%$7.23
38

Other major holders of RGNX: BlackRock Finance, Inc., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used